CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
1.264
-0.036 (-2.78%)
Mar 31, 2025, 10:51 AM EDT - Market open
CNS Pharmaceuticals Employees
As of December 31, 2023, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,411,337
Market Cap
1.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5 | 0 | - |
| Dec 31, 2022 | 5 | 0 | - |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | 0 | - |
| Dec 31, 2019 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CNSP News
- 5 days ago - CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects - Benzinga
- 6 days ago - CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Accesswire
- 4 weeks ago - CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing - Accesswire
- 5 weeks ago - CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum - Accesswire
- 5 weeks ago - CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Accesswire
- 5 weeks ago - CNS Pharmaceuticals Announces Reverse Stock Split - Accesswire
- 5 weeks ago - CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit - Accesswire
- 7 weeks ago - CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference - Accesswire